La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Driven Brands Hldgs a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Driven Brands Hldgs..

Driven Brands Hldgs (NASDAQ:DRVN) Azioni, Catena delle Opzioni

Driven Brands Hldgs

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.

Driven Brands Holdings

Driven Brands Holdings Inc. - Common Stock

Driven Brands Holdings Inc

DA Davidson analyst Manuel Navas maintains Fulton Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULT#NASDAQ">FULT</a>) with a Neutral and lowers the price target from $20 to $17.

News

Price Target

Analyst Ratings

FULT

DA Davidson Maintains Neutral on Fulton Financial, Lowers Price Target to $17

DA Davidson analyst Peter Winter maintains U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) with a Buy and lowers the price target from $54 to $49.

DA Davidson Maintains Buy on U.S. Bancorp, Lowers Price Target to $49

DA Davidson analyst Peter Heckmann maintains Donnelley Financial Solns (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFIN#NYSE">DFIN</a>) with a Buy and lowers the price target from $72 to $64.

DFIN

DA Davidson Maintains Buy on Donnelley Financial Solns, Lowers Price Target to $64

WIIM

BBWI

ETSY

FIVE

JEWL

LEVI

OLLI

ULTA

URBN

Shares of retail, apparel and e-commerce stocks are trading higher. Some stocks in the sector may be higher amid hopes of a US-China trade deal. Additionally, discount store stocks could be benefitting from broader economic concerns. E-commerce stocks may also be up up Chinese discount retailers Temu and Shein planning to increase prices.

Editor&rsquo;s note: This article was originally published in May 2024. Some time references have been updated as of April 2025 for clarity and context.
&ldquo;Imagine if it was never prohibited. <a href="https://www.benzinga.com/cannabis">Cannabis</a> would be a trillion-dollar industry that was ours,&rdquo; says <a href="https://elplanteo.com/dreka-gates/">Dreka Gates</a> in an exclusive interview, reflecting on the historical and social implications of cannabis prohibition and its disproportionate impact on Black and Brown communities in America and beyond. As an accomplished entrepreneur &ndash; and wife of rapper Kevin Gates, Dreka is carving out a significant space for herself in the wellness and cannabis industries, driven by a profound personal connection to plant medicine.
Dreka&#39;s journey with cannabis began in her teen years with a challenging first encounter. &quot;My first time smoking was an absolutely horrible experience,&quot; she admits. Paranoia and anxiety marked her initial attempt, but her curiosity pushed her to try again. This time, cannabis provided a sense of relaxation and openness that became central to her wellness routine. Today, Dreka uses cannabis to manage anxiety and incorporates other therapeutic plants and fungi into her daily regimen. &quot;I also microdose with psychedelic mushrooms for healing past traumas and functional mushrooms daily,&quot; she explains.
Her holistic approach to wellness is deeply rooted in personal experience and education. Dreka took a three-day crash course at Oaksterdam University in Oakland in 2016, which covered everything from seed to sale, business and growing aspects of cannabis. This foundation empowered her to enter the cannabis industry with confidence and expertise.
<h3>A Crop Harvested With Love</h3>
In 2021, a Michigan-based cannabis company offered Dreka a partnership, where she took on roles in marketing and research and development. This opportunity was a stepping stone to her solo venture, Love&#39;s Harvest, based in Mississippi.
<img alt="Dreka Gates" src="https://imageio.forbes.com/specials-images/imageserve/66467015fbaf8728f0e4ab30/Dreka-Gates/960x0.jpg?format=jpg&amp;width=1440" style="height:450px; width:296px" />
Dreka Gates. SHANNON LAURINEX
&quot;Love&#39;s Harvest is my love, my harvest,&quot; she says, describing her cannabis operation. Her vision for Love&#39;s Harvest is to create a space that educates and destigmatizes cannabis use, particularly in the conservative Bible Belt. &quot;I&#39;m still in the Bible Belt, and a lot of people still look at it like, &#39;Oh, that&#39;s dope, that&#39;s a drug,&#39;&quot; she explains.
However, she is confident in her ability to educate and transform these outdated views, showing that cannabis can be a powerful tool for wellness and healing. &quot;You can literally just plant a seed outside in your backyard and you don&#39;t have to do anything to it. It&#39;ll just grow and it&#39;ll just be there. How can this possibly be illegal?&quot; she adds.
<h3>Weed Wellness</h3>
The wellness market in the U.S. is booming,&nbsp;<a href="https://www.luxurytribune.com/en/the-wellness-industry-a-market-valued-at-1-5-trillion-dollars" rel="nofollow noopener noreferrer" target="_blank" title="https://www.luxurytribune.com/en/the-wellness-industry-a-market-valued-at-1-5-trillion-dollars">valued</a>&nbsp;at over $1.5 trillion and still projected to grow steadily each year. Similarly, the cannabis market is experiencing rapid expansion, with&nbsp;<a href="https://www.forbes.com/sites/irisdorbian/2021/06/18/legal-cannabis-market-projected-to-rack-up-43-billion-by-2025-says-new-study/?sh=557f6d8e36b4" target="_self" title="https://www.forbes.com/sites/irisdorbian/2021/06/18/legal-cannabis-market-projected-to-rack-up-43-billion-by-2025-says-new-study/?sh=557f6d8e36b4">estimates</a>&nbsp;suggesting it could reach $43 billion in 2025 &mdash; a milestone the industry is now approaching. Dreka&#39;s dual focus on wellness and cannabis positions her uniquely at the intersection of these lucrative industries. She has been developing a line of products that blend cannabis with other herbs and plants, including topicals, pills and edibles. &quot;Some people are so accustomed to taking pills,&quot; she notes, &quot;so we have those too.&quot;
<img alt="Dreka Gates" src="https://imageio.forbes.com/specials-images/imageserve/66466feb6f70c796d21d2f57/Dreka-Gates/960x0.jpg?format=jpg&amp;width=1440" style="height:416px; width:624px" />
Dreka Gates. SHANNON LAURINEX
Her efforts aim to make medication approachable and enjoyable. &quot;It&#39;s instilled in us that medication has to feel bad to be therapeutic,&quot; she reflects. Dreka challenges this notion by offering products that are both effective and pleasant to use. &quot;But aside from that, it has so many benefits recreationally and medicinally. For those people that just want to take the edge off after they get home from a long day&#39;s work or something, it&#39;s good for that.&quot; Her goal is to meet people where they are, providing options that suit different preferences and lifestyles.
Dreka&#39;s holistic approach to wellness extends beyond the physical products she offers. She is also passionate about creating experiences that foster healing and growth. She has hosted retreats and pop-up events designed to merge wellness and cannabis, offering participants a comprehensive approach to health that addresses mental, physical and spiritual needs. &quot;My intention is to create educational programs and retreats where people can experience what it&#39;s like for wellness and cannabis to be one,&quot; she says.
The wellness retreats feature a variety of activities, including yoga, meditation and educational workshops on the benefits of cannabis and other plant medicines. These events are part of her broader vision to destigmatize cannabis and integrate it into mainstream wellness practices. &quot;Cannabis is just another plant that has the ability to really heal and make us feel better,&quot; Dreka asserts.
<h3>&lsquo;Lock In On That Vision And Just Go For It&rsquo;</h3>
Dreka&#39;s dedication to wellness and cannabis isn&#39;t just about personal gain; it&#39;s about community empowerment and education. Her path took a significant turn when she and her husband, Kevin Gates, co-founded the Breadwinners Association. Initially a record label, the Breadwinners Association expanded its work into the lifestyle realm, creating a brand that resonated deeply with the Gates&rsquo; audience. &quot;It&#39;s all about building a solid foundation and creating an organic community,&quot; she says.
<img alt="Dreka Gates" src="https://imageio.forbes.com/specials-images/imageserve/664670a79db3fcef0cfedaac/Dreka-Gates/960x0.jpg?format=jpg&amp;width=1440" style="height:450px; width:297px" />
Dreka Gates. SHANNON LAURINEX
This philosophy seamlessly transitioned into her wellness and cannabis businesses. At Love&#39;s Harvest, Dreka aims to provide a sanctuary where people can learn about and experience the benefits of cannabis in a supportive environment. &quot;I want people to walk in and feel like they&#39;re being transported to a different place,&quot; she explains, discussing her dispensary. In fact, the store is a place reminiscent of Tulum, Mexico, a nod to where her healing journey began, she says.
Dreka&#39;s entrepreneurial journey is marked by a relentless pursuit of her vision, despite numerous challenges. She acknowledges the obstacles she has faced, particularly as a woman in a male-predominantly industry like entertainment is. Yet, her experience with cannabis has been different: &quot;Most of the people I interact with in the cannabis space are women,&quot; she notes, challenging the perception of cannabis as a male-dominated field. What&rsquo;s more, Dreka encourages other women to pursue their passions in the industry, emphasizing that they too can create their own space and make a significant impact.
Her background in the entertainment industry has equipped her with unique skills that she applies to her cannabis and wellness ventures. From booking gigs for Kevin at $250 to negotiating six-figure deals, Dreka has honed her business acumen and strategic thinking. These experiences have taught her the importance of risk-taking and staying true to one&#39;s vision. &quot;Once you have your vision, lock in on that vision and just go for it,&quot; she advises. &quot;Be creative and do what feels good to you.&quot;
<h3>A Mission To Destigmatize Cannabis</h3>
One of Dreka&#39;s key initiatives is developing a line of products that combine cannabis with other beneficial herbs and plants. &quot;We&#39;re doing an entire line,&quot; she says, emphasizing the variety of products she plans to introduce. These products are not only intended for recreational use but are also formulated to address specific health concerns, making them a versatile addition to the wellness market.
Dreka&#39;s commitment to education is a cornerstone of her business strategy. She understands that changing perceptions about cannabis requires more than just offering products; it involves educating the public about the plant&#39;s benefits and uses. Through Love&#39;s Harvest, she aims to provide a space where people can learn about cannabis in a supportive and informative environment. &quot;My intention is to destigmatize the use of cannabis and to make it not so taboo,&quot; she explains.
In addition to her product lines and educational efforts, Dreka is also focused on creating community-driven experiences. Her retreats and pop-up events offer participants an immersive experience that combines wellness practices with cannabis education. These events provide an opportunity for individuals to explore the benefits of cannabis in a holistic setting, fostering a deeper understanding and appreciation of the plant.
<img alt="Dreka Gates" src="https://imageio.forbes.com/specials-images/imageserve/664670c1091d57f90faf7f84/Dreka-Gates/960x0.jpg?format=jpg&amp;width=1440" style="height:416px; width:624px" />
Dreka Gates. SHANNON LAURINEX
Dreka&#39;s approach to business is deeply personal, drawing on her own experiences and passions. She sees herself as a healer at heart, a role that guides her work in both the wellness and cannabis industries. &quot;I&#39;m sharing tools for healing past traumas and achieving full-body wellness. I&#39;m working on sex and love certification, being a doula, and creating educational programs and retreats.&quot; This perspective is reflected in her plans for future ventures, which include expanding her reach and influence through collaborations and partnerships.
As cannabis rescheduling becomes more likely, Dreka remains optimistic about the future of the cannabis and wellness industries. She believes that as more people become educated about the benefits of cannabis, societal perceptions will continue to shift, leading to greater acceptance and integration of the plant into mainstream wellness practices. &quot;I&#39;m just here having fun and living out my purpose,&quot; she concludes, displaying the joy and fulfillment she finds in her work. &quot;Women should just go for it and create their own space in cannabis.&quot;
Follow me on&nbsp;<a href="https://www.twitter.com/javierhasse" rel="nofollow noopener noreferrer" target="_blank">Twitter</a>&nbsp;or&nbsp;<a href="https://www.linkedin.com/in/javierhasse/" rel="nofollow noopener noreferrer" target="_blank">LinkedIn</a>.&nbsp;Check out&nbsp;my&nbsp;<a href="https://elplanteo.com/" rel="nofollow noopener noreferrer" target="_blank">website</a>&nbsp;or&nbsp;some of my other work&nbsp;<a href="https://benzinga.com/cannabis" rel="nofollow noopener noreferrer" target="_blank">here</a>.&nbsp;
This article was originally published on <a href="https://www.forbes.com/sites/javierhasse/2024/05/17/dreka-gates-cannabis-would-be-a-trillion-dollar-industry-for-black-brown-communities-if-it-had-never-been-illegal/">Forbes</a> and appears here with permission.&nbsp;The article is from an external source. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.
Photo by&nbsp;Shannon Laurinex, courtesy of Dreka Gates.

Cannabis

Markets

General

Dreka Gates: 'Cannabis Would Be A Trillion-Dollar Industry For Black And Brown Communities—If It Hadn't Been Criminalized'

Plug Power, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares are <a target="_blank" href="https://www.benzinga.com/news" rel="noreferrer noopener">trading lower on Thursday</a>. The company&#8217;s joint venture with Olin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>), named Hidrogenii, officially launched operations at its new hydrogen liquefaction facility in St. Gabriel, Louisiana—one of the largest of <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44860452/hidrogenii-a-plug-and-olin-joint-venture-commissions-15-ton-per-day-hydrogen-liquefaction-plant-in" rel="noreferrer noopener">its kind in North America.</a>
The plant, capable of liquefying up to 15 metric tons of hydrogen per day, will serve Plug&#8217;s material handling customers nationwide.
The move marks a significant step toward building a robust U.S.-based hydrogen supply chain and underscores Plug&#8217;s ongoing effort to scale its green energy production network, the company said in a press release.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/25/04/44868280/us-listed-chinese-stocks-face-250-billion-forced-selling-risk-as-delisting-fears-emerge-what-investors-need-to-know" rel="noreferrer noopener">US-Listed Chinese Stocks Face $250 Billion Forced Selling Risk As Delisting Fears Emerge: What Investors Need To Know</a>
Hydrogen for the St. Gabriel plant will be produced by Olin and distributed via trailers under Plug&#8217;s spot pricing model.
With this addition, Plug&#8217;s total hydrogen production capacity now reaches 40 metric tons per day, including output from its existing Georgia and Tennessee facilities.
The company emphasized the cost and reliability benefits of sourcing domestically produced hydrogen, which reduces its reliance on external suppliers.
&#8220;This Louisiana plant, a milestone in expanding our U.S. hydrogen network, bolsters our financial position by leveraging a dependable, cost-effective hydrogen source,&#8221; said Andy Marsh, CEO of Plug Power.
He noted that this development helps strengthen the company&#8217;s operational foundation while supporting growth.
Ken Lane, President and CEO of Olin, described the joint venture as aligned with Olin&#8217;s strategic priorities. Lane called it &#8220;a value-first approach&#8221; that builds on core competencies through adjacent, capital-efficient projects.
Formed in 2022, Hidrogenii was created to develop and operate hydrogen infrastructure.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, PLUG stock has lost over 66% in the past year. Investors can gain exposure to the stock via&nbsp;Global X Hydrogen ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYDR#NASDAQ">HYDR</a>).
Price Action: PLUG shares are trading lower by 1.79% to $0.90 at last check on Thursday.
Read Now:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44862662/trump-pressures-fed-as-ecb-delivers-7th-straight-rate-cut" target="_blank" rel="noreferrer noopener">Trump Pressures Fed As ECB Delivers 7th Straight Rate Cut</a></li>
</ul>
Photo by T. Schneider via Shutterstock

Equities

Movers

HYDR

PLUG

What's Going On With Plug Power Stock On Thursday?

During an official Oval Office meeting with Italian Prime Minister Giorgia Meloni, President Donald Trump reignited his push against Federal Reserve Chair Jerome Powell, warning he could remove him if rate cuts don't come soon—just hours after another round of <a href="https://www.benzinga.com/government/regulations/25/04/44862662/trump-pressures-fed-as-ecb-delivers-7th-straight-rate-cut">policy easing from Europe.</a>
On Thursday, Trump and Meloni addressed reporters following bilateral talks on trade, China, Ukraine and broader transatlantic relations. The Italian leader praised her host's role in global affairs, saying: "The goal for me is to make the West great again."
Yet, Trump swiftly redirected the focus toward domestic monetary policy, using the moment to sharply criticize Powell.
<h3 class="wp-block-heading">&#8216;Oh, He'll Leave&#8217;</h3>
Trump accused the Fed chair of playing politics and holding rates unnecessarily high despite disinflationary signals across major sectors.
"He's too late. Always too late. A little slow. And I'm not happy with him," Trump said, adding, "Oh, if I want him out, he'll be out of there real fast. Believe me." He continued: "He'll be out of there if I ask him."
Powell's term as Fed chair runs through May 2026, and he has previously defended the central bank's independence by noting that his position is protected by statute. A Federal Reserve chair can only be removed for cause, which has historically been interpreted as misconduct or incapacity—not policy disagreements.
Trump pointed directly to the ECB's aggressive monetary easing as a model the Fed should follow. 
"In Europe, they've reduced [rates] seven times… but our guy wants to play cute," he said, warning that keeping U.S. rates higher puts the economy at a disadvantage.
The U.S. Dollar Index – as tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) – was up 0.2% on Thursday, yet it has fallen by more than 10% since Trump&#8217;s inauguration in January. 
<h3 class="wp-block-heading">Inflation Is Essentially Gone, Trump Says</h3>
The president claimed that inflation is no longer a concern, arguing that falling oil, grocery and egg prices show clear evidence of relief. "We essentially have no inflation. It's hard to have inflation when oil goes down," he said.
Trump insisted the Fed is the only institution holding back the economy, saying, "Interest rates should be down now… they're not very smart. The Federal Reserve is playing politics."
"We're essentially being played by our own central bank," he added. 
As Trump left the podium Thursday, he summed up his stance plainly: "The Fed owes it to the American people to get interest rates down. That's the only thing he's good for."
<h3 class="wp-block-heading">Meloni Meeting Covers Trade, China, Ukraine</h3>
Meloni hinted at a deeper NATO commitment, signaling Italy's increasing willingness to meet defense spending targets. 
The two also briefly discussed China, with Trump noting, "We're doing very well with negotiations… everyone wants to make a deal. If they don't, we'll make it for them."
A U.S.-Ukraine mineral deal is expected to be signed next Thursday, as part of efforts to deepen Western investment and counter Russian influence.
Trump reiterated his skepticism toward Ukrainian President Volodymyr Zelenskyy, stating, "I'm not a big fan of Zelenskyy. He hasn't done a good job."
Read now: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44873779/wall-street-rebounds-eli-lilly-rallies-unitedhealth-group-plummets-whats-driving-markets-thursday">Wall Street Rebounds, Eli Lilly Rallies, UnitedHealth Group Plummets: What&#8217;s Driving Markets Thursday?</a></li>
</ul>
Photo: noamgalai/Shutterstock

Macro Economic Events

Eurozone

Politics

Econ #s

Economics

PowerShares DB US Dollar Index Bullish Fund

'He'll Be Out... If I Ask Him': Can Trump's Threat To Oust Powell Shake The Fed?

On Thursday, Keybanc analyst Steve Barger downgraded Amkor Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) from <a href="https://www.benzinga.com/quote/AMKR/analyst-ratings" target="_blank" rel="noreferrer noopener">Overweight to Sector Weight</a>.
The rerating reflects reduced visibility into demand for mobile phones, automobiles, and consumer products, which stems from fluctuating trade policy.
Also Read: <a href="https://www.benzinga.com/news/earnings/25/04/44851295/asml-cfo-incorporates-tariff-impact-in-outlook-reveals-strong-demand-for-advanced-euv-and-high-na-systems" target="_blank" rel="noreferrer noopener">ASML CFO Incorporates Tariff Impact In Outlook, Reveals Strong Demand For Advanced EUV And High NA Systems</a>
Barger noted that it could exacerbate the expected gross margin pressure in the first half of 2025 due to a temporary socket loss in its Mobile end market and expressed concern about Amkor&#8217;s inherently lower-visibility but relatively high-capex business model.
The analyst noted that shares will likely remain under pressure until major end markets like Automotive and Mobile show signs of stabilization and growth.
Amkor automotive sales generally track the major automotive semiconductor companies, and while consensus estimates indicate a return to growth in the second half of 2025, Barger noted that company commentary combined with volatile global trade rhetoric suggests a cautious approach to shares in the near term.
In a broader upcycle scenario, the analyst noted Amkor should exhibit substantial operating leverage on higher factory utilization, but that will require recovery and growth across high-volume end markets for that to happen.
As one of a handful of outsourced manufacturing companies able to process 2.5D advanced packages with acceptable yield and throughput, Barger noted Amkor will continue to focus on high-performance computing as a margin-accretive and higher-growth vector.
The analyst noted volumes are still too small to drive consolidated company outperformance, absent participation from traditional end markets. Amkor could remain a &#8220;second choice&#8221; for leading-edge chip companies behind the technology leader, Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>).
Barger lowered his estimates to reflect heightened uncertainty in global trade and end demand. The analyst&#8217;s 2025 estimate goes to $1.40 from $1.48 (consensus $1.41), reflecting a -2% growth rate at a 6% decremental margin. His 2026 estimate goes to $1.91 from $2.04 (consensus $1.96), reflecting 9% growth on a 34% incremental margin.
Given the recent share price action, Barger acknowledged that his downgrade was reactive. Still, when he noted the market position and the potential impact of reduced demand across mobile phones, autos, and other consumer products, he had less confidence in predicting near-term outcomes for Amkor than for some other names he covered.
For now, Barger noted that the demand for AI-related devices and investments in leading-edge roadmaps should remain resilient, and he is more positive about names exposed to upgrade cycles or where channel inventory has been reduced, like memory. Looking forward, when this macro angst passes and improving cycle dynamics become more apparent, the analyst could be quick to reverse course, but for now, he noted more positive outlooks for Overweight-rated Applied Materials, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>), Lam Research Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), Advanced Energy Industries, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEIS#NASDAQ">AEIS</a>) and MKS Instruments, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>).
Price Action: AMKR stock is down 0.33% at $16.10 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44841545/applied-materials-lam-research-kla-drop-amid-fresh-trade-war-fears-revenue-risk" target="_blank" rel="noreferrer noopener">Applied Materials, Lam Research, KLA Drop Amid Fresh Trade War Fears, Revenue Risk</a></li>
</ul>
Image: Shutterstock

Downgrades

Trading Ideas

AEIS

AMAT

AMKR

LRCX

MKSI

Amkor Stock Under Pressure: Analyst Cuts Rating Due To Trade Policy Concerns, Slowing End Market Growth

Goldman Sachs analyst John Mackay shared views on Kinder Morgan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>), which reported first-quarter earnings <a href="https://www.benzinga.com/news/earnings/25/04/44852989/kinder-morgan-q1-earnings-revenue-beat-eps-miss-forward-guidance-our-company-can-be-a-safe-haven-during-the-storm" target="_blank" rel="noreferrer noopener">on Wednesday after market close</a>.
The energy infrastructure company reported revenue of $4.24 billion, missing the consensus estimate of $4.08 billion, and adjusted quarterly earnings of 34 cents per share, which fell short of analyst estimates of <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">35 cents per share</a>.
Kinder Morgan expects full-year 2025 earnings of $1.27 per share versus&nbsp;Benzinga Pro&nbsp;estimates of $1.28 per share and net income attributable to the company <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">to be up 8% compared to 2024</a>.
Mackay writes that weaker-than-expected product performance, largely due to maintenance on a condensate splitter, contributed to the earnings shortfall, though the gas business remains healthy.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44541993/kinder-morgan-set-for-q1-growth-amid-rising-lng-demand-says-analyst" rel="noreferrer noopener">Goldman Sachs Forecasts High Gas Prices And LNG Demand Drive Kinder Morgan&#8217;s Revenue</a>
Management expressed confidence in achieving its full-year 2025 EBITDA target of approximately $8.35 billion, even in a less favorable economic environment (vs. GS estimates: $8.32 billion; consensus: $8.37 billion), the analyst notes.
Overall, the analyst believes that the reaffirmed EBITDA outlook, growing backlog, and strong demand signals paint a constructive picture.
Mackay says that for the rest of the year, key areas of focus include how the broader economic environment aligns with what was originally factored into company guidance, especially given recent pricing trends that show strength. At the same time, future commodity prices and volumes could soften.
Attention will also be on upcoming announcements for both smaller and larger-scale projects, with interest in how these initiatives progress in the near term, adds the analyst.
The analyst reiterated a Buy rating <a target="_blank" href="https://www.benzinga.com/quote/KMI/analyst-ratings" rel="noreferrer noopener">with a price target of $31</a>.
Investors can gain exposure to the stock through the Global X MLP &amp; Energy Infrastructure ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLPX#NYSE">MLPX</a>) and the Ultimus Managers Trust Westwood Salient Enhanced Midstream Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDST#NYSE">MDST</a>).
Price Action: KMI shares are up 1.86% at $27.45 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43540757/oil-prices-trim-losses-as-department-of-treasury-issues-sanctions-on-irans-crude-shipments-to-china" target="_blank" rel="noreferrer noopener">Oil Prices Trim Losses As Department Of Treasury Issues Sanctions On Iran&#8217;s Crude Shipments To China</a></li>
</ul>
Photo: Shutterstock

Large Cap

Reiteration

MDST

MLPX

Kinder Morgan's Backlog And Demand Trends Keep 2025 EBITDA On Track, Says Goldman

LXEH

Lixiang Education Holding Shares Halted On Circuit Breaker To The Downside, Stock Now Down -23.7%

UBS analyst Peter Grom maintains YETI Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YETI#NYSE">YETI</a>) with a Neutral and lowers the price target from $43 to $31.

YETI

UBS Maintains Neutral on YETI Holdings, Lowers Price Target to $31

Thermo Fisher Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $629.44, with a high estimate of $715.00 and a low estimate of $475.00. Experiencing a 2.53% decline, the current average is now lower than the previous average price target of $645.78. 
<img src="https://www.benzinga.com/files/images/story/2025/1744916464_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of Thermo Fisher Scientific by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Brandon Couillard &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $580.00&#x7C;$680.00 &#x7C; 
&#x7C;Luke Sergott &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $475.00&#x7C;$620.00 &#x7C; 
&#x7C;Patrick Donnelly &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $570.00&#x7C;$650.00 &#x7C; 
&#x7C;Sung Ji Nam &#x7C;Scotiabank &#x7C;Raises &#x7C;Sector Perform &#x7C; $650.00&#x7C;$605.00 &#x7C; 
&#x7C;Andrew Cooper &#x7C;Raymond James &#x7C;Raises &#x7C;Outperform &#x7C; $667.00&#x7C;$650.00 &#x7C; 
&#x7C;Patrick Donnelly &#x7C;Citigroup &#x7C;Raises &#x7C;Neutral &#x7C; $650.00&#x7C;$600.00 &#x7C; 
&#x7C;Dan Leonard &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $715.00&#x7C;$700.00 &#x7C; 
&#x7C;Brandon Couillard &#x7C;Wells Fargo &#x7C;Raises &#x7C;Overweight &#x7C; $680.00&#x7C;$660.00 &#x7C; 
&#x7C;Tejas Savant &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $678.00&#x7C;$647.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Thermo Fisher Scientific. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Thermo Fisher Scientific compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Thermo Fisher Scientific's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Thermo Fisher Scientific's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TMO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Thermo Fisher Scientific analyst ratings.</a>
<h2>All You Need to Know About Thermo Fisher Scientific</h2>
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
<h3>Understanding the Numbers: Thermo Fisher Scientific's Finances</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Over the 3M period, Thermo Fisher Scientific showcased positive performance, achieving a revenue growth rate of 4.68% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Thermo Fisher Scientific's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 16.06% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.71%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Thermo Fisher Scientific's ROA stands out, surpassing industry averages. With an impressive ROA of 1.85%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Thermo Fisher Scientific's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.63.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Thermo Fisher Scientific: Insights From 9 Financial Analysts

Financial giants have made a conspicuous bullish move on JD.com. Our analysis of options history for JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) revealed 33 unusual trades.
Delving into the details, we found 60% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 17 were puts, with a value of $1,703,637, and 16 were calls, valued at $1,066,568.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $30.0 to $40.0 for JD.com during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for JD.com's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of JD.com's whale trades within a strike price range from $30.0 to $40.0 in the last 30 days. 
<h3>JD.com Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744916463_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$4.4</td>
<td>$4.3</td>
<td>$4.37</td>
<td>$37.50</td>
<td>$681.7K</td>
<td>16.6K</td>
<td>2.0K</td>
</tr>
<tr>
<td>JD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$1.39</td>
<td>$1.35</td>
<td>$1.38</td>
<td>$31.00</td>
<td>$344.9K</td>
<td>1.4K</td>
<td>2.5K</td>
</tr>
<tr>
<td>JD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$8.85</td>
<td>$8.55</td>
<td>$8.82</td>
<td>$35.00</td>
<td>$131.9K</td>
<td>580</td>
<td>205</td>
</tr>
<tr>
<td>JD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$6.5</td>
<td>$6.45</td>
<td>$6.49</td>
<td>$30.00</td>
<td>$129.7K</td>
<td>3.3K</td>
<td>518</td>
</tr>
<tr>
<td>JD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$6.5</td>
<td>$6.45</td>
<td>$6.48</td>
<td>$30.00</td>
<td>$116.6K</td>
<td>3.3K</td>
<td>180</td>
</tr>
</tbody>
</table>

<h3>About JD.com</h3>
JD.com is the third-largest Chinese e-commerce platform by GMV in 2024. it offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
In light of the recent options history for JD.com, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of JD.com</h3>
<ul>
<li>Currently trading with a volume of 9,543,647, the JD's price is down by -0.76%, now at $35.06. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 28 days.</li>
</ul>
<h3>Expert Opinions on JD.com</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $48.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on JD.com with a target price of $48. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest JD.com options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

This Is What Whales Are Betting On JD.com

Deep-pocketed investors have adopted a bullish approach towards Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMD usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 73 extraordinary options activities for Advanced Micro Devices. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 57% leaning bullish and 30% bearish. Among these notable options, 45 are puts, totaling $3,121,011, and 28 are calls, amounting to $1,915,075.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $60.0 to $260.0 for Advanced Micro Devices during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Advanced Micro Devices's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Advanced Micro Devices's whale activity within a strike price range from $60.0 to $260.0 in the last 30 days. 
<h3>Advanced Micro Devices Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744916458_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/25/25</td>
<td>$2.46</td>
<td>$2.43</td>
<td>$2.45</td>
<td>$87.00</td>
<td>$502.2K</td>
<td>1.1K</td>
<td>4.0K</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/17/27</td>
<td>$29.6</td>
<td>$29.25</td>
<td>$29.4</td>
<td>$100.00</td>
<td>$441.0K</td>
<td>824</td>
<td>167</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$10.5</td>
<td>$10.4</td>
<td>$10.45</td>
<td>$85.00</td>
<td>$209.0K</td>
<td>11.1K</td>
<td>955</td>
</tr>
<tr>
<td>AMD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$3.85</td>
<td>$3.75</td>
<td>$3.8</td>
<td>$110.00</td>
<td>$155.4K</td>
<td>2.6K</td>
<td>1.2K</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$4.85</td>
<td>$4.85</td>
<td>$4.85</td>
<td>$70.00</td>
<td>$130.4K</td>
<td>5.8K</td>
<td>413</td>
</tr>
</tbody>
</table>

<h3>About Advanced Micro Devices</h3>
Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers, industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox. In 2022, the firm acquired field-programmable gate array leader Xilinx to diversify its business and augment its opportunities in key end markets such as data center and automotive.
After a thorough review of the options trading surrounding Advanced Micro Devices, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Advanced Micro Devices Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 25,325,341, with AMD's price down by -0.68%, positioned at $87.69.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 19 days.</li>
</ul>
<h3>What The Experts Say On Advanced Micro Devices</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $124.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Citigroup has decided to maintain their Neutral rating on Advanced Micro Devices, which currently sits at a price target of $100. 
&#x2A; An analyst from Jefferies has revised its rating downward to Hold, adjusting the price target to $120. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Advanced Micro Devices with a target price of $120. 
&#x2A; Consistent in their evaluation, an analyst from Evercore ISI Group keeps a Outperform rating on Advanced Micro Devices with a target price of $126. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for Advanced Micro Devices, targeting a price of $155. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Advanced Micro Devices options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Advanced Micro Devices's Options Frenzy: What You Need to Know

Across the recent three months, 5 analysts have shared their insights on Itron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRI#NASDAQ">ITRI</a>), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $130.6, a high estimate of $133.00, and a low estimate of $124.00. This current average has increased by 1.87% from the previous average price target of $128.20. 
<img src="https://www.benzinga.com/files/images/story/2025/1744916456_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A comprehensive examination of how financial experts perceive Itron is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Joseph Osha &#x7C;Guggenheim &#x7C;Maintains &#x7C;Buy &#x7C; $133.00&#x7C;$133.00 &#x7C; 
&#x7C;Joseph Osha &#x7C;Guggenheim &#x7C;Lowers &#x7C;Buy &#x7C; $133.00&#x7C;$135.00 &#x7C; 
&#x7C;Kashy Harrison &#x7C;Piper Sandler &#x7C;Raises &#x7C;Neutral &#x7C; $124.00&#x7C;$119.00 &#x7C; 
&#x7C;Austin Moeller &#x7C;Canaccord Genuity &#x7C;Raises &#x7C;Buy &#x7C; $132.00&#x7C;$130.00 &#x7C; 
&#x7C;Noah Kaye &#x7C;Oppenheimer &#x7C;Raises &#x7C;Outperform &#x7C; $131.00&#x7C;$124.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Itron. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Itron compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Itron's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Itron's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ITRI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Itron analyst ratings.</a>
<h2>Discovering Itron: A Closer Look</h2>
Itron Inc provides solutions that measure, manage, and analyze energy and water use. It operates under the Itron brand and manages and reports under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sense that do not have communications capability embedded for use with broader Itron systems. The Networked Solutions segment includes a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution. The Outcome segment includes their value-added, enhanced software and services which manage, organize, analyze, and interpret data to improve decision-making and maximize operational profitability.
<h3>Unraveling the Financial Story of Itron</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Over the 3M period, Itron showcased positive performance, achieving a revenue growth rate of 6.18% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Itron's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 9.48%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Itron's ROE excels beyond industry benchmarks, reaching 4.24%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.72%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 0.91, Itron faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ITRI

Beyond The Numbers: 5 Analysts Discuss Itron Stock

Investors with a lot of money to spend have taken a bearish stance on Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with FICO, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for Fair Isaac.
This isn't normal.
The overall sentiment of these big-money traders is split between 30% bullish and 60%, bearish.
Out of all of the options we uncovered, 9 are puts, for a total amount of $479,660, and there was 1 call, for a total amount of $29,189.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $1760.0 and $2550.0 for Fair Isaac, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Fair Isaac's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Fair Isaac's significant trades, within a strike price range of $1760.0 to $2550.0, over the past month.
<h3>Fair Isaac 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744916453_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$154.1</td>
<td>$150.0</td>
<td>$154.05</td>
<td>$1920.00</td>
<td>$77.0K</td>
<td align="right">65</td>
<td align="right">25</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$153.0</td>
<td>$150.0</td>
<td>$153.0</td>
<td>$1920.00</td>
<td>$76.5K</td>
<td align="right">65</td>
<td align="right">10</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$147.6</td>
<td>$141.0</td>
<td>$144.75</td>
<td>$1900.00</td>
<td>$72.3K</td>
<td align="right">14</td>
<td align="right">0</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$644.0</td>
<td>$635.0</td>
<td>$635.0</td>
<td>$2550.00</td>
<td>$63.5K</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$158.0</td>
<td>$154.0</td>
<td>$158.0</td>
<td>$1920.00</td>
<td>$47.4K</td>
<td align="right">65</td>
<td align="right">4</td>
</tr>
</tbody>
</table>

<h3>About Fair Isaac</h3>
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
In light of the recent options history for Fair Isaac, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Fair Isaac's Current Market Status</h3>
<ul>
<li>With a trading volume of 64,822, the price of FICO is up by 1.13%, reaching $1921.17.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 12 days from now.</li>
</ul>
<h3>What The Experts Say On Fair Isaac</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $2375.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $2500. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Fair Isaac, targeting a price of $2250. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Fair Isaac, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

FICO

This Is What Whales Are Betting On Fair Isaac

Throughout the last three months, 4 analysts have evaluated F N B (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNB#NYSE">FNB</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $18.25, a high estimate of $20.00, and a low estimate of $16.00. Highlighting a 2.67% decrease, the current average has fallen from the previous average price target of $18.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1744916444_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of F N B among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Manuel Navas &#x7C;DA Davidson &#x7C;Maintains &#x7C;Buy &#x7C; $19.00&#x7C;$19.00 &#x7C; 
&#x7C;Jared Shaw &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $16.00&#x7C;$18.00 &#x7C; 
&#x7C;Frank Schiraldi &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Overweight &#x7C; $18.00&#x7C;$19.00 &#x7C; 
&#x7C;Russell Gunther &#x7C;DA Davidson &#x7C;Raises &#x7C;Buy &#x7C; $20.00&#x7C;$19.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to F N B. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of F N B compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for F N B's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of F N B's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FNB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on F N B analyst ratings.</a>
<h2>Delving into F N B's Background</h2>
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial &amp; consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets &amp; lease financing. Consumer banking products &amp; services include deposit products, mortgage lending, &amp; consumer lending &amp; a complete suite of mobile &amp; online banking services.
<h3>Unraveling the Financial Story of F N B</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Positive Revenue Trend: Examining F N B's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 10.36% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: F N B's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 29.49%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): F N B's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 1.75%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): F N B's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.23%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: F N B's debt-to-equity ratio stands notably higher than the industry average, reaching 0.59. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

F N B Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) underwent analysis by 21 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">9</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">6</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $147.19, a high estimate of $250.00, and a low estimate of $100.00. This current average represents a 11.86% decrease from the previous average price target of $167.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1744916435_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Advanced Micro Devices among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Timothy Arcuri &#x7C;UBS &#x7C;Lowers &#x7C;Buy &#x7C; $155.00&#x7C;$175.00 &#x7C; 
&#x7C;Aaron Rakers &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $120.00&#x7C;$140.00 &#x7C; 
&#x7C;Mark Lipacis &#x7C;Evercore ISI Group &#x7C;Lowers &#x7C;Outperform &#x7C; $126.00&#x7C;$147.00 &#x7C; 
&#x7C;Christopher Danely &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $100.00&#x7C;$110.00 &#x7C; 
&#x7C;Blayne Curtis &#x7C;Jefferies &#x7C;Lowers &#x7C;Hold &#x7C; $120.00&#x7C;$135.00 &#x7C; 
&#x7C;Vijay Rakesh &#x7C;Mizuho &#x7C;Lowers &#x7C;Outperform &#x7C; $120.00&#x7C;$140.00 &#x7C; 
&#x7C;Cody Acree &#x7C;Benchmark &#x7C;Maintains &#x7C;Buy &#x7C; $170.00&#x7C;$170.00 &#x7C; 
&#x7C;Vijay Rakesh &#x7C;Mizuho &#x7C;Lowers &#x7C;Outperform &#x7C; $140.00&#x7C;$160.00 &#x7C; 
&#x7C;Ruben Roy &#x7C;Stifel &#x7C;Lowers &#x7C;Buy &#x7C; $162.00&#x7C;$200.00 &#x7C; 
&#x7C;Christopher Rolland &#x7C;Susquehanna &#x7C;Lowers &#x7C;Positive &#x7C; $150.00&#x7C;$165.00 &#x7C; 
&#x7C;Harsh Kumar &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Overweight &#x7C; $140.00&#x7C;$180.00 &#x7C; 
&#x7C;Joseph Moore &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $137.00&#x7C;$147.00 &#x7C; 
&#x7C;Aaron Rakers &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $140.00&#x7C;$165.00 &#x7C; 
&#x7C;Cody Acree &#x7C;Benchmark &#x7C;Lowers &#x7C;Buy &#x7C; $170.00&#x7C;$200.00 &#x7C; 
&#x7C;Vivek Arya &#x7C;B of A Securities &#x7C;Lowers &#x7C;Neutral &#x7C; $135.00&#x7C;$155.00 &#x7C; 
&#x7C;John Vinh &#x7C;Keybanc &#x7C;Lowers &#x7C;Overweight &#x7C; $140.00&#x7C;$150.00 &#x7C; 
&#x7C;Joseph Moore &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $147.00&#x7C;$158.00 &#x7C; 
&#x7C;Hans Mosesmann &#x7C;Rosenblatt &#x7C;Maintains &#x7C;Buy &#x7C; $250.00&#x7C;$250.00 &#x7C; 
&#x7C;Christopher Rolland &#x7C;Susquehanna &#x7C;Lowers &#x7C;Positive &#x7C; $165.00&#x7C;$200.00 &#x7C; 
&#x7C;Ben Reitzes &#x7C;Melius Research &#x7C;Lowers &#x7C;Hold &#x7C; $129.00&#x7C;$160.00 &#x7C; 
&#x7C;Christopher Danely &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $175.00&#x7C;$200.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Advanced Micro Devices. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Advanced Micro Devices compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
To gain a panoramic view of Advanced Micro Devices's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/AMD/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Advanced Micro Devices analyst ratings.</a>
<h2>Delving into Advanced Micro Devices's Background</h2>
Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers, industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox. In 2022, the firm acquired field-programmable gate array leader Xilinx to diversify its business and augment its opportunities in key end markets such as data center and automotive.
<h3>Advanced Micro Devices: Delving into Financials</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Advanced Micro Devices's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 24.16%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: Advanced Micro Devices's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 6.29%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Advanced Micro Devices's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.84%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Advanced Micro Devices's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.69%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.04.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

21 Analysts Have This To Say About Advanced Micro Devices

Motorola Solutions's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>) short percent of float has risen 13.33% since its last report. The company recently reported that it has 2.23 million shares sold short, which is 1.53% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.02 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Motorola Solutions Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744916431_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Motorola Solutions has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Motorola Solutions's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Motorola Solutions's peer group average for short interest as a percentage of float is 6.80%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

What Does the Market Think About Motorola Solutions?

UBS analyst Josh Silverstein maintains Tourmaline Oil (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TOU#TSX">TOU</a>) with a Neutral and lowers the price target from C$74 to C$71.

TSX:TOU

UBS Maintains Neutral on Tourmaline Oil, Lowers Price Target to C$71

Legal

Press Releases

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors

Alert to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); General Motors Company (NYSE: GM); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and ModivCare, Inc. (NASDAQ: MODV): Act Now as Grabar Law Office Is Investigating Claims on Your Behalf

DRIVEN BRANDS INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Driven Brands Holdings Inc. - DRVN

Kuehn Law Encourages Investors of Driven Brands Holdings Inc. to Contact Law Firm

Driven Brands Holdings Inc. (NASDAQ: DRVN) Long-Term Shareholder Alert: Grabar Law Investigates Claims on Your Behalf as Securities Fraud Class Action Survives Motion to Dismiss

Notice to Long-Term Shareholders of Driven Bands Holdings, Inc. (NASDAQ: DRVN); ModivCare, Inc. (NASDAQ: MODV); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial Inc. (NASDAQ: VIRT), Grabar Law Office Investigates Claims on Your Behalf

Driven Brands Announces Closing of Sale of U.S. Car Wash Business

Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf

SECURITIES FRAUD CLASS ACTIONS HAVE SURVIVED MOTIONS TO DISMISS: Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); and Virtu Financial Inc. (NASDAQ: VIRT) Should Contact Grabar Law Office Today

SECURITIES FRAUD CLASS ACTIONS HAVE SURVIVED MOTIONS TO DISMISS: Long-Term Shareholders of Driven Bands Holdings, Inc. (NASDAQ: DRVN); Maison Solutions Inc. (NASDAQ: MSS); Mercury Systems, Inc. (NASDAQ: MRCY); and Virtu Financial Inc. (NASDAQ: VIRT) Should Contact Grabar Law Office Today

Comments

Driven Brands Hldgs

Driven Brands Hldgs (DRVN) Opzioni

Driven Brands Hldgs (NASDAQ:DRVN) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO